Cash flow Canopy Growth Corporation

Equities

WEED

CA1380357048

Pharmaceuticals

Delayed Toronto S.E. Other stock markets 09:59:15 2026-03-05 am EST			5-day change	1st Jan Change
1.470 ^CAD	-0.68%		-5.77%	-5.77%

Feb. 23	Mtl Cannabis obtains final court approval for plan of arrangement with Canopy Growth	RE
Feb. 23	MTL Cannabis Brief: Says Obtained Final Court Approval for Plan of Arrangement with Canopy Growth	MT

68116e1b286.ShM4e9AfNeekntrdMa4RnIXBTe4HBLm-CtGCiqIZ3L0.IltyKJRpVJTX1Ym7Zc9f-OKSH580NPGHPY7z5utpsu0IeGFKgHdaoO6uvQ

Published financial data: CANOPY GROWTH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	547M	520M	403M	297M	269M
Total Revenues	547M	520M	403M	297M	269M
Cost of Goods Sold, Total	454M	602M	418M	217M	187M
Gross Profit	92.94M	-81.94M	-15.26M	79.9M	81.5M
Selling General & Admin Expenses, Total	573M	505M	423M	195M	150M
Stock-Based Compensation (IS)	91.15M	47.52M	31.19M	14.18M	-4.2M
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses, Total	664M	552M	455M	209M	146M
Operating Income	-571M	-634M	-470M	-129M	-64.4M
Interest Expense, Total	-8.46M	-104M	-126M	-105M	-74.57M
Interest And Investment Income	21.37M	6.6M	24.28M	16.24M	8.82M
Net Interest Expenses	12.91M	-97.34M	-102M	-89.12M	-65.75M
Income (Loss) On Equity Invest.	-52.63M	-100K	-	-	-
Currency Exchange Gains (Loss)	-18.01M	5.42M	-8.53M	704K	1.49M
Other Non Operating Income (Expenses)	-882M	1.12B	-145M	-173M	-402M
EBT, Excl. Unusual Items	-1.51B	398M	-726M	-390M	-531M
Restructuring Charges	-554M	-426M	-548M	-5.65M	-33.22M
Merger & Related Restructuring Charges	-13.52M	-22.91M	-35.69M	-34.77M	-
Impairment of Goodwill	-	-40.75M	-1.79B	-42.08M	-
Gain (Loss) On Sale Of Investments	435M	-277M	-252M	18.27M	-
Gain (Loss) On Sale Of Assets	-	-6.76M	2.41M	-	-
Asset Writedown	-6.63M	-26.06M	-14.61M	-17.27M	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-34.26M	71.72M	43.97M	181K	-32.71M
EBT, Incl. Unusual Items	-1.68B	-329M	-3.31B	-471M	-597M
Income Tax Expense	-13.14M	-8.95M	-4.77M	12.33M	7.14M
Earnings From Continuing Operations	-1.67B	-320M	-3.31B	-484M	-604M
Earnings Of Discontinued Operations	-	-	-	-174M	6.02M
Net Income to Company	-1.67B	-320M	-3.31B	-657M	-598M
Minority Interest	-74.1M	18.3M	31.39M	-	-
Net Income - (IS)	-1.74B	-302M	-3.28B	-657M	-598M
Net Income to Common Incl Extra Items	-1.74B	-302M	-3.28B	-657M	-598M
Net Income to Common Excl. Extra Items	-1.74B	-302M	-3.28B	-484M	-604M
Per Share Items
Net EPS - Basic	-46.95	-7.72	-70.69	-8.79	-5.56
Basic EPS - Continuing Operations	-46.95	-7.72	-70.69	-6.47	-5.62
Basic Weighted Average Shares Outstanding	37.17M	39.13M	46.37M	74.79M	108M
Net EPS - Diluted	-46.95	-7.72	-70.7	-8.79	-5.56
Diluted EPS - Continuing Operations	-46.95	-7.72	-70.7	-6.47	-5.62
Diluted Weighted Average Shares Outstanding	37.17M	39.13M	46.37M	74.79M	108M
Normalized Basic EPS	-27.39	6.83	-9.1	-3.26	-3.09
Normalized Diluted EPS	-27.39	6.83	-9.1	-3.26	-3.09
Supplemental Items
EBITDA	-444M	-520M	-385M	-75.77M	-21.28M
EBITA	-515M	-596M	-442M	-104M	-42.8M
EBIT	-571M	-634M	-470M	-129M	-64.4M
EBITDAR	-433M	-514M	-375M	-67.24M	-9.21M
Total Revenues (As Reported)	547M	520M	403M	297M	269M
Effective Tax Rate - (Ratio)	0.78	2.72	0.14	-2.62	-1.2
Current Domestic Taxes	19.32M	-895K	-4.78M	462K	-79K
Current Foreign Taxes	2.09M	-1.48M	676K	-194K	418K
Total Current Taxes	21.41M	-2.37M	-4.11M	268K	339K
Deferred Domestic Taxes	-36.5M	-6.35M	3.6M	12.6M	7.01M
Deferred Foreign Taxes	1.96M	-224K	-4.27M	-537K	-204K
Total Deferred Taxes	-34.55M	-6.58M	-667K	12.06M	6.8M
Normalized Net Income	-1.02B	267M	-422M	-244M	-332M
Interest on Long-Term Debt	1.67M	1.67M	2.02M	1.84M	1.42M
Supplemental Operating Expense Items
Advertising Expense	72.38M	104M	134M	28.66M	22.91M
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	57.58M	32.34M	21.72M	4.61M	2.74M
Net Rental Expense, Total	10.85M	5.24M	10.61M	8.53M	12.07M
Imputed Operating Lease Interest Expense	626K	2.6M	7.01M	6.91M	14.17M
Imputed Operating Lease Depreciation	10.22M	2.65M	3.6M	1.62M	-2.1M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	91.15M	47.52M	31.19M	14.18M	-4.2M
Total Stock-Based Compensation	91.15M	47.52M	31.19M	14.18M	-4.2M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.15B	776M	677M	170M	114M
Short Term Investments	1.16B	606M	107M	35.53M	17.81M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	2.32B	1.38B	784M	206M	132M
Accounts Receivable, Total	67.11M	78.06M	66.82M	44.94M	47.51M
Other Receivables	25.33M	18.38M	27.17M	6.9M	5.27M
Total Receivables	92.44M	96.44M	93.99M	51.85M	52.78M
Inventory	369M	205M	150M	78.05M	96.37M
Prepaid Expenses	28.35M	23.04M	27.46M	6.62M	5.36M
Other Current Assets, Total	30.4M	31.28M	21.88M	28.84M	8.44M
Total Current Assets	2.84B	1.74B	1.08B	371M	295M
Gross Property Plant And Equipment	1.3B	1.18B	611M	418M	405M
Accumulated Depreciation	-223M	-233M	-112M	-98.18M	-112M
Net Property Plant And Equipment	1.07B	943M	499M	320M	294M
Long-term Investments	708M	336M	206M	180M	35.29M
Goodwill	1.89B	1.87B	85.56M	43.24M	46.04M
Other Intangibles, Total	308M	253M	189M	104M	87.2M
Loans Receivable Long-Term	-	85.54M	8.5M	8.37M	145M
Other Long-Term Assets, Total	4.96M	394M	374M	273M	16.38M
Total Assets	6.82B	5.62B	2.44B	1.3B	918M
Liabilities
Accounts Payable, Total	67.26M	64.27M	76.23M	28.67M	26.1M
Accrued Expenses, Total	55.86M	32.51M	37.16M	27.32M	16.43M
Current Portion of Long-Term Debt	9.83M	9.3M	557M	104M	4.26M
Current Portion of Leases	42.06M	38.04M	28.68M	15.17M	16.54M
Current Income Taxes Payable	-	7.14M	5.73M	10.52M	13.07M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	109M	61.64M	99.14M	49.1M	18M
Total Current Liabilities	284M	213M	804M	235M	94.4M
Long-Term Debt	1.57B	1.49B	750M	493M	300M
Long-Term Leases	94.16M	101M	80.62M	55.6M	27.79M
Deferred Tax Liability Non Current	21.38M	15.99M	357K	-	-
Other Non Current Liabilities	1.23B	163M	44.26M	16.22M	8.49M
Total Liabilities	3.2B	1.98B	1.68B	800M	430M
Common Stock, Total	7.17B	7.48B	7.94B	8.24B	8.8B
Additional Paid In Capital	2.42B	2.52B	2.51B	2.6B	2.62B
Retained Earnings	-6.07B	-6.37B	-9.67B	-10.33B	-10.93B
Comprehensive Income and Other	-34.24M	-42.28M	-13.86M	-16.05M	535K
Total Common Equity	3.48B	3.59B	758M	500M	487M
Minority Interest	140M	40.54M	1.59M	139K	-
Total Equity	3.62B	3.63B	760M	501M	487M
Total Liabilities And Equity	6.82B	5.62B	2.44B	1.3B	918M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	38.3M	40.29M	58.66M	76.2M	185M
ECS Total Common Shares Outstanding	38.29M	39.44M	51.73M	91.12M	184M
Book Value / Share	90.94	91.02	14.66	5.49	2.65
Tangible Book Value	1.28B	1.47B	484M	353M	354M
Tangible Book Value Per Share	33.54	37.29	9.36	3.88	1.93
Total Debt	1.72B	1.64B	1.42B	668M	348M
Net Debt	-598M	258M	632M	462M	217M
Debt Equivalent Oper. Leases	86.77M	41.96M	84.86M	68.22M	96.54M
Minority Interest, Total (Incl. Fin. Div)	140M	40.54M	1.59M	139K	-
Equity Method Investments, Total	100K	-	-	-	33.14M
Account Code - Inventory Valuation	6	8	8	8	8
Inventories - Raw Materials, Total	55.55M	26.82M	28.98M	18.87M	16.27M
Inventories - Work In Process, Total	224M	65.24M	34.1M	31.37M	46.94M
Inventories - Finished Goods, Total	88.77M	112M	85.82M	27.05M	33.16M
Inventories - Others	-	-	-	-	-
Land - (BS)	34.75M	18.92M	16.78M	5.32M	4.99M
Buildings, Total	651M	767M	414M	306M	305M
Machinery, Total	274M	211M	124M	80.85M	82.14M
Full Time Employees	3.26K	3.15K	1.62K	1.03K	960
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	1.41M	4.76M	9.3M	9.9M	1.21M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-1.74B	-302M	-3.28B	-657M	-598M
Depreciation & Amortization - CF	70.91M	76.25M	56.74M	28.38M	21.52M
Amortization of Goodwill and Intangible Assets - (CF)	56.2M	38.17M	27.78M	24.8M	21.6M
Depreciation & Amortization, Total	127M	114M	84.52M	53.18M	43.12M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	109M	-	-	-	-
Asset Writedown & Restructuring Costs	534M	333M	2.23B	53.8M	20.28M
(Income) Loss On Equity Investments - (CF)	52.63M	100K	-	-	-
Stock-Based Compensation (CF)	91.15M	47.52M	31.19M	14.18M	-4.2M
Net Cash From Discontinued Operations	-	-	-	-53.53M	-
Other Operating Activities, Total	369M	-904M	311M	304M	405M
Change In Accounts Receivable	-11.99M	3.74M	-9.91M	-3.75M	-4.48M
Change In Inventories	17.21M	173M	55.64M	1.03M	-17.72M
Change In Accounts Payable	-9.63M	-35.84M	17.63M	9.12M	-15.48M
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	77K	24.47M	2.48M	-2.43M	5.72M
Cash from Operations	-466M	-546M	-558M	-282M	-166M
Capital Expenditure	-165M	-36.68M	-9.22M	-3.45M	-10.81M
Sale of Property, Plant, and Equipment	45.92M	27.28M	13.61M	154M	4.93M
Cash Acquisitions	-153M	-14.95M	-24.22M	-	-
Divestitures	-	118M	14.93M	-955K	-6.97M
Sale (Purchase) of Intangible assets	8.7M	-11.43M	-1.34M	-547K	-467K
Investment in Marketable and Equity Securities, Total	-498M	167M	435M	78.2M	-78.91M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-57M	-	-	-	30.31M
Other Investing Activities, Total	-66.75M	-18.13M	4.18M	14.29M	14.13M
Cash from Investing	-884M	231M	433M	242M	-47.79M
Long-Term Debt Issued, Total	893M	-	135M	-	68.26M
Total Debt Issued	893M	-	135M	-	68.26M
Long-Term Debt Repaid, Total	-15.62M	-50.76M	-118M	-510M	-289M
Total Debt Repaid	-15.62M	-50.76M	-118M	-510M	-289M
Issuance of Common Stock	402M	8.27M	1.33M	81.06M	394M
Other Financing Activities, Total	-14.86M	-3.04M	-38M	-36.34M	-24.52M
Cash from Financing	1.26B	-45.53M	-19.69M	-465M	149M
Foreign Exchange Rate Adjustments	-63.46M	-18.12M	44.86M	-1.29M	8.39M
Net Change in Cash	-149M	-379M	-99M	-507M	-56.49M
Supplemental Items
Cash Interest Paid	25.65M	119M	132M	98.12M	64.9M
Cash Income Tax Paid (Refund)	18.7M	1.34M	-4.33M	-4.16M	655K
Levered Free Cash Flow	-372M	-249M	-162M	-48.84M	-98.82M
Unlevered Free Cash Flow	-366M	-184M	-83.22M	17M	-52.22M
Change In Net Working Capital	71.96M	-98.19M	-105M	-34.24M	39.6M
Net Debt Issued / Repaid	878M	-50.76M	16.98M	-510M	-221M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-5.22	-6.37	-7.3	-4.31	-3.63
Return on Total Capital	-6.41	-7.47	-7.9	-4.82	-4.02
Return On Equity %	-37.97	-8.84	-151.11	-76.74	-122.33
Return on Common Equity	-41.7	-8.55	-151	-76.85	-122.35
Margin Analysis
Gross Profit Margin %	17	-15.75	-3.79	26.89	30.3
SG&A Margin	104.8	96.98	105.09	65.51	55.8
EBITDA Margin %	-81.21	-99.87	-95.64	-25.5	-7.91
EBITA Margin %	-94.19	-114.52	-109.73	-35.05	-15.91
EBIT Margin %	-104.47	-121.86	-116.62	-43.39	-23.94
Income From Continuing Operations Margin %	-305.65	-61.59	-821.42	-162.78	-224.59
Net Income Margin %	-319.2	-58.08	-813.63	-221.19	-222.35
Net Avail. For Common Margin %	-319.2	-58.08	-813.63	-162.78	-224.59
Normalized Net Income Margin	-186.24	51.36	-104.77	-82.04	-123.39
Levered Free Cash Flow Margin	-68	-47.9	-40.22	-16.44	-36.74
Unlevered Free Cash Flow Margin	-67.03	-35.41	-20.65	5.72	-19.41
Asset Turnover
Asset Turnover	0.08	0.08	0.1	0.16	0.24
Fixed Assets Turnover	0.42	0.52	0.56	0.75	0.88
Receivables Turnover (Average Receivables)	9.24	7.17	5.97	6.89	5.82
Inventory Turnover (Average Inventory)	1.16	2.1	2.36	2.68	2.16
Short Term Liquidity
Current Ratio	9.98	8.16	1.34	1.58	3.12
Quick Ratio	8.48	6.94	1.09	1.1	1.95
Operating Cash Flow to Current Liabilities	-1.64	-2.56	-0.69	-1.2	-1.76
Days Sales Outstanding (Average Receivables)	39.49	50.92	61.16	53.11	62.73
Days Outstanding Inventory (Average Inventory)	314.47	174.03	154.75	136.43	169.04
Average Days Payable Outstanding	84.68	54.85	70.69	52.38	48.39
Cash Conversion Cycle (Average Days)	269.27	170.09	145.22	137.16	183.38
Long Term Solvency
Total Debt/Equity	47.47	45.18	186.34	133.46	71.51
Total Debt / Total Capital	32.19	31.12	65.08	57.17	41.69
LT Debt/Equity	46.03	43.87	109.29	109.67	67.24
Long-Term Debt / Total Capital	31.22	30.22	38.17	46.97	39.2
Total Liabilities / Total Assets	46.92	35.34	68.84	61.51	46.91
EBIT / Interest Expense	-67.51	-6.1	-3.72	-1.22	-0.86
EBITDA / Interest Expense	-51.2	-4.95	-2.97	-0.64	-0.12
(EBITDA - Capex) / Interest Expense	-70.65	-5.3	-3.04	-0.67	-0.27
Total Debt / EBITDA	-3.97	-3.19	-3.78	-9.93	-37.83
Net Debt / EBITDA	1.38	-0.5	-1.69	-6.87	-23.54
Total Debt / (EBITDA - Capex)	-2.88	-2.98	-3.69	-9.45	-17.4
Net Debt / (EBITDA - Capex)	1	-0.47	-1.65	-6.54	-10.83
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	37.08	-4.82	-21.05	-10.83	-9.47
Gross Profit, 1 Yr. Growth %	-11.56	-192.34	-83.42	379.19	2.01
EBITDA, 1 Yr. Growth %	-41.82	15.95	-27.25	-68.22	-71.92
EBITA, 1 Yr. Growth %	-38.47	14.8	-27.04	-64.58	-58.9
EBIT, 1 Yr. Growth %	-35.7	10.22	-27.05	-59.51	-50.06
Earnings From Cont. Operations, 1 Yr. Growth %	20.42	-80.82	901.17	-84.3	24.9
Net Income, 1 Yr. Growth %	32.06	-82.68	957.32	-79.95	-9
Normalized Net Income, 1 Yr. Growth %	279.13	-126.18	-260.4	-30.45	42.85
Diluted EPS Before Extra, 1 Yr. Growth %	23.66	-83.55	792.35	-90.26	-13.15
Accounts Receivable, 1 Yr. Growth %	31.15	16.32	-2.02	8.84	5.72
Inventory, 1 Yr. Growth %	-10.39	-44.56	-27.02	-7	24.69
Net Property, Plant and Equip., 1 Yr. Growth %	-29.53	-12.26	-47.02	-32.08	-8.3
Total Assets, 1 Yr. Growth %	-0.5	-17.71	-56.49	-46.7	-29.43
Tangible Book Value, 1 Yr. Growth %	-47.7	14.52	-66.94	-31.06	0.25
Common Equity, 1 Yr. Growth %	-28.74	3.11	-78.84	-34.03	-2.63
Cash From Operations, 1 Yr. Growth %	-39.72	17.19	2.15	-49.43	-41.21
Capital Expenditures, 1 Yr. Growth %	-76.66	-77.7	-74.87	-62.16	213.51
Levered Free Cash Flow, 1 Yr. Growth %	-62.27	-33.42	-33.97	-43.88	102.34
Unlevered Free Cash Flow, 1 Yr. Growth %	-62.64	-50.07	-53.89	-307.94	-407.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	55.41	14.23	-14.15	-20.97	-10.16
Gross Profit, 2 Yr. CAGR %	81.4	-9.66	-58.18	2.33	121.09
EBITDA, 2 Yr. CAGR %	-11.52	-17.73	-7.43	-59.38	-70.13
EBITA, 2 Yr. CAGR %	-7.15	-15.85	-7.85	-55.9	-61.85
EBIT, 2 Yr. CAGR %	-3.56	-15.73	-9.74	-52.45	-55.03
Earnings From Cont. Operations, 2 Yr. CAGR %	53.19	-51.94	40.74	36.68	-55.71
Net Income, 2 Yr. CAGR %	53.95	-52.18	37.07	45.6	-57.29
Normalized Net Income, 2 Yr. CAGR %	36.96	-21.91	-24.98	43.26	-2.69
Diluted EPS Before Extra, 2 Yr. CAGR %	30.48	-54.9	22.71	-0.29	-70.91
Accounts Receivable, 2 Yr. CAGR %	4.18	23.52	-0.21	-18.82	7.27
Inventory, 2 Yr. CAGR %	32.22	-29.52	-36.37	-38.3	7.16
Net Property, Plant and Equip., 2 Yr. CAGR %	-1	-21.37	-31.82	-41.73	-21.08
Total Assets, 2 Yr. CAGR %	-10.74	-9.51	-40.21	-51.84	-38.67
Tangible Book Value, 2 Yr. CAGR %	-47.91	-22.61	-38.6	-50.9	-16.86
Common Equity, 2 Yr. CAGR %	-28.34	-14.29	-53.33	-62.63	-19.85
Cash From Operations, 2 Yr. CAGR %	-6.7	-15.95	9.41	-28.13	-45.48
Capital Expenditures, 2 Yr. CAGR %	-49.48	-77.19	-76.33	-69.34	8.92
Levered Free Cash Flow, 2 Yr. CAGR %	-31.53	-49.77	-34.28	-51.02	6.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	-31.52	-56.72	-52.57	-64.98	152.7
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	91.41	31.98	0.34	-18.39	-17.31
Gross Profit, 3 Yr. CAGR %	41.24	42.62	-46.64	-2.89	2.22
EBITDA, 3 Yr. CAGR %	66.78	-2.87	-20.53	-44.77	-64.09
EBITA, 3 Yr. CAGR %	70.2	-0.07	-19.31	-41.51	-56.92
EBIT, 3 Yr. CAGR %	70.02	1.07	-19.26	-39.31	-51.67
Earnings From Cont. Operations, 3 Yr. CAGR %	219.84	-23.36	33.61	-33.85	32.64
Net Income, 3 Yr. CAGR %	196	-25.69	35.38	-27.78	24.49
Normalized Net Income, 3 Yr. CAGR %	208.54	-21.03	-1.24	-31.25	40.85
Diluted EPS Before Extra, 3 Yr. CAGR %	131.28	-34.58	23.03	-48.35	-4.77
Accounts Receivable, 3 Yr. CAGR %	125.36	8.08	9.31	-12.51	-11.35
Inventory, 3 Yr. CAGR %	42.86	-1.04	-28.68	-40.44	-22.24
Net Property, Plant and Equip., 3 Yr. CAGR %	52.38	-4.91	-31.07	-33.21	-32.22
Total Assets, 3 Yr. CAGR %	68.09	-13.13	-29.15	-42.45	-45.29
Tangible Book Value, 3 Yr. CAGR %	20.05	-32.26	-41.8	-34.98	-37.71
Common Equity, 3 Yr. CAGR %	44.3	-19.1	-46.26	-47.62	-48.58
Cash From Operations, 3 Yr. CAGR %	78.78	0.67	-10.3	-15.4	-32.78
Capital Expenditures, 3 Yr. CAGR %	-2.22	-61.53	-76.44	-72.43	-33.45
Levered Free Cash Flow, 3 Yr. CAGR %	25.86	-32.01	-45.26	-49.32	-21.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	25.37	-38.22	-56.1	-64.18	-27.78
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	112.22	67.14	38.89	5.59	-7.57
Gross Profit, 5 Yr. CAGR %	37.39	16.18	-14.29	23.12	-4.09
EBITDA, 5 Yr. CAGR %	243.6	275.94	32.13	-33.14	-51.19
EBITA, 5 Yr. CAGR %	238.88	161.88	33.46	-29.48	-44.88
EBIT, 5 Yr. CAGR %	236.79	148.33	32.24	-26.81	-40.9
Earnings From Cont. Operations, 5 Yr. CAGR %	243.46	111.5	130.32	-7.44	-15.32
Net Income, 5 Yr. CAGR %	246.45	109.31	117.54	-2.24	-14.66
Normalized Net Income, 5 Yr. CAGR %	293.16	125.5	64.86	-14.79	-5.41
Diluted EPS Before Extra, 5 Yr. CAGR %	152.89	64.97	79.49	-25.18	-31.76
Accounts Receivable, 5 Yr. CAGR %	127.14	94.64	62.69	-6.18	-1.47
Inventory, 5 Yr. CAGR %	68.16	27.54	3.37	-18.06	-25.23
Net Property, Plant and Equip., 5 Yr. CAGR %	89.23	57.83	10.46	-21.82	-28.07
Total Assets, 5 Yr. CAGR %	116.53	51.54	11.16	-31.41	-33.12
Tangible Book Value, 5 Yr. CAGR %	78.76	44.17	-8.19	-40.49	-32.12
Common Equity, 5 Yr. CAGR %	94.91	41.19	-8.13	-40.62	-36.94
Cash From Operations, 5 Yr. CAGR %	102.95	82.32	46.9	-12.03	-26.5
Capital Expenditures, 5 Yr. CAGR %	68.26	4.53	-44.56	-64.87	-56.63
Levered Free Cash Flow, 5 Yr. CAGR %	69.8	35.73	-2.76	-42.73	-36.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	69.43	27.78	-14.85	-53.49	-44.41